Hostname: page-component-7b7567c8c-p67k6 Total loading time: 0 Render date: 2026-11-19T10:15:50.427Z Has data issue: false hasContentIssue false

Tuberculin Skin Testing of Hospitalized Patients

Published online by Cambridge University Press:  02 January 2015

Keith F. Woeltje
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
Charles M. Kilo
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
Krista Johnson
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
Jonathon Primack
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
Victoria J. Fraser*
Affiliation:
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, St Louis, Missouri
*
Department of Internal Medicine, Infectious Diseases Division, Washington University School of Medicine, Campus Box 8061, 660 South Euclid, St Louis, MO 63110

Abstract

Objectives:

We sought to define the prevalence of tuberculin skin test (TST) positivity in a group of newly hospitalized patients, to identify risk factors for positive tests, and to examine the impact of testing on infection control practices.

Design:

Unblinded cohort study over 5 days in July 1992.

Setting:

A 1,000-bed university-affiliated hospital.

Patients:

All patients admitted (excluding obstetric patients and newborns) were interviewed. Patients without a history of tuberculosis (TB) or a positive TST were offered a TST with Candida and tetanus controls.

Results:

Of 346 patients offered the test, 21 (6%) had a prior history of TB or a positive TST, and 36 (10%) declined to participate; 279 of the remaining 289 completed the study. Anergy was demonstrated in 94 (33.7%) of 279 patients. New positive TSTs were identified in 19 (10.3%) of 185 nonanergic patients. Of the 19 TST-positive patients, 6 (32%) had infiltrates on chest radiographs and were evaluated for active TB. One patient was treated empirically for active TB, and five received isoniazid prophylaxis. Risk factors for a new positive TST included age (odds ratio [OR], 1.56 per decade of life; P=.021), African American race (OR, 4.81; P=.008), alcohol abuse (OR, 5.53; P=.005), and peptic ulcer disease (OR, 4.53; P=.017). Risk factors for anergy included admission to a surgical service (OR, 2.1; P=.006), current use of steroids (OR, 2.65; P=.005), and human immunodeficiency virus (HIV) infection (OR, undefined; P=.034).

Conclusions:

Despite a high rate of anergy, routine tuberculin skin testing identified a substantial number of patients with TB infection who might otherwise have gone unrecognized.

Information

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1997 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable